Sat, Dec 27, 2014, 2:14 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

QUALCOMM Incorporated Message Board

nameofthegame777 9 posts  |  Last Activity: Dec 17, 2014 6:39 PM Member since: Apr 13, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • OCAT is trading on the Boerse Stuttgart stock exchange.
    (Google) Boerse Stuttgart stock exchange

    I have seen this exchange destroy many a good company stock price.

    If this is NOT something you want, and it shouldn't be something (Ocat)
    management should want either. The company needs to hire a lawyer
    and demand that OCAT be delisted immediately. It's not hard to do, but its
    does take an effort by the company to have the request and the necessary
    steps needed to be remove from the Berlin stock exchange.

    By the by, if you are unaware, its one of 3 top "naked" short exchanges.....
    along with the Berlin exchange, that you don't want to have your company
    shares listed on. Anything and everything can happen in a SMALL SPEC
    company's quiet period,

    Let's not have an auspicious new beginning to Ocata Therapeutics

    I have been involved in over 9 success public company turn arounds form the inside.

    (OCAT) is also quoted on Bloomberg as trading on the Stuttgart exchange
    T2N1 or T2N1.ag You can also

  • Reply to

    Macau

    by nameofthegame777 Dec 15, 2014 7:26 PM
    nameofthegame777 nameofthegame777 Dec 15, 2014 7:27 PM Flag

    This will eventually have an effect on American casino companies that have made more money from Macau than from Las Vegas the past few years.

    Companies such as Wynn, Las Vegas Sands, and MGM Grand have created separate subsidiaries for their Macau businesses, but they're still subject to US laws, like the Foreign Corrupt Practices Act.

    Regulators are investigating Sands over allegations of bribery in Macau, and Wynn has disclosed that it is being investigated for alleged violations of the FCPA. If found guilty, the Nevada Gaming Control Board could revoke their licenses.

    All these companies have ties to the junkets, of course. Some junkets have even brought revenue to Las Vegas.

    Cheung's Neptune is one of three Macau junkets that have been allowed to bring high rollers to Las Vegas, something Nevada regulators have been watching with mounting concern.

    Wynn and MGM both used Neptune chairman, Lin Cheuk Fung, as an agent from 2005 to 2009. That means Lin arranged for wealthy gamblers to head to MGM and Wynn casinos to play. The problem is that it's not a very transparent process, and regulators don't have a full handle on who those gamblers are.

    "We're getting to understand the junkets and how the VIP rooms operate," Nevada Gaming Control Board member A.G. Burnett told Reuters in October. "We haven't decided whether that's offensive to the way we operate."

    In Cheung's case, Nevada may be much closer to coming to a decision. One of his companies has been connected to an illegal World Cup gambling ring that was busted in Las Vegas this summer. Eight people were arrested in the sting, and based on computers and cellphones that federal agents collected from the Caesars Palace villas where they stayed, Cheung's companies were helping the alleged ring settle up with gamblers.

    What all this means is that once-thought-untouchable junket operators need to be on their guard from now on, and Macau's VIP rooms will suffer for that.

  • nameofthegame777 by nameofthegame777 Dec 15, 2014 7:26 PM Flag

    Reuters It's now undeniable that Chinese President Xi Jinping's corruption crackdown will change Macau's casino business forever.

    Cheung Chi Tai, a powerful junket operator, is being investigated for money laundering. The FBI had been monitoring him as an alleged member of the Triad, China's fearsome mafia, since 1992.

    He was once the largest shareholder of one of Macau's biggest junkets, Neptune Guangdong Group, and continues to have ties to the company.

    As the investigation proceeds, Cheung's assets have been frozen, according to The Wall Street Journal. In other words, Hong Kong regulators are very serious this time, and if someone as powerful as Cheung can go down in flames, no one in Macau's junket world is immune.

    Junkets made $30 billion for Macau last year by providing financing for casino high rollers — mostly from mainland China. That's about 70% of Macau's casino revenue, according to Reuters.

    Investors give junket operators money in exchange for guaranteed returns of about 1% to 2%. However, since this spring, when one junket operator stole $1 billion in cash from the pool, investors have wanted higher returns for perceived additional risk.

    This has already started breaking down the island's casino industry. At first, analysts were hopeful, believing that a free fall in casino revenue that started this summer would somehow find a stopping point, or that a higher volume of retail gamblers would make up for lost high rollers. But none of that has happened.

  • Part 1

    From the Wall Street Journal - Japan
    8:39 pm JST
    Apr 28, 2014

    Japanese Nobel Winner Latest to Apologize Over Stem-Cell Research

    A scandal involving Japanese stem-cell research took a surprising turn Monday when the nation’s most revered researcher in the field, Nobel Prize laureate Shinya Yamanaka, apologized for what he described as poor record-keeping.

    The apology came after months of soul-searching in Japan over research ethics. A researcher at the prestigious Riken institute, Haruko Obokata, apologized earlier this month after admitting errors in a paper in the journal Nature that described a possible new method of creating stem cells.

    Last week, the head of the Riken panel investigating Dr. Obokata had to resign from the panel after admitting that a paper he co-authored used some of the same improper methods of cutting and pasting images that he had criticized in Dr. Obokata’s work.

    On Monday evening, Dr. Yamanaka, a professor at Kyoto University, spoke at a news conference after questions arose about an image in a 2000 paper on which he was the lead author. In the paper, Dr. Yamanaka, then at Nara University, described a protein that played a role in turning embryo cells into cells specific to a part of the body.

    The university said it conducted an investigation after Dr. Yamanaka informed administrators about allegations he discovered online that an image in the paper was doctored. It didn’t identify the party raising the allegations.
    Kyoto University said it found no problem with the paper’s conclusions, but Dr. Yamanaka acknowledged that he no longer had the lab records that would support the validity of the images.

    “I would like to express remorse from my heart and apologize,” he said.

  • Reply to

    Clear headed thinking by management

    by nameofthegame777 Aug 27, 2014 6:52 PM
    nameofthegame777 nameofthegame777 Aug 27, 2014 10:36 PM Flag

    jnichols_9627111 "Wow 6 posts since 2011... I hear you....and thanks for the wisdom...Thump up...."

    I used to post periodically on Yahoo until the format change.
    You can go to stocktwits under nameofthegame7. Archive my posts.
    I don't post they any more, I was just trying to help a few investors
    try and make back some of the money they previously lost. Nothing to prove here.
    I will not be responding to anymore of your posts. Have a nice evening

  • nameofthegame777 by nameofthegame777 Aug 27, 2014 6:52 PM Flag

    I don't post much. I have personally been involved in many a turn around plays of public stocks at the absolute bottom in price. ACTC is beginning to act like all great turn around stories do. They have a corporate road map, and now they have a highly regarded CEO. If as an investor you have been successful in buying turn story stocks at the bottom you should be happy if you bought Advanced Cell Tech between .06 - .07 recently. Clear headed thinking by management to do what needed to be done before not after the highly anticipated peer review report is released as the company has increased the ability of biotech funds and funds in general by several 100s of percent that will be able to buy ACTC stock and most importantly the stock is now margin-able.

  • Reply to

    This is CEO Dr. Wotton public address

    by nameofthegame777 Aug 8, 2014 4:53 PM
    nameofthegame777 nameofthegame777 Aug 8, 2014 6:30 PM Flag

    What are you talking about. IF the stock falls down to the .06 level I would be willing to buy some more shares. I already have a full position, so if it did drop to .06 it would be willing to buy a 4th wave. Don't try and imply what my motives are other than what I've stated, period

  • Reply to

    This is CEO Dr. Wotton public address

    by nameofthegame777 Aug 8, 2014 4:53 PM
    nameofthegame777 nameofthegame777 Aug 8, 2014 5:38 PM Flag

    A final point, I have accumulated a very nice position between .06 - .062 If the market is willing to sell me more shares at that .06 buy point again, I will be there to complete my 4th and final wave, call it a bonus wave of buying. I do this professionally for a living and I'M VERY GOOD AT WHAT I DO.

  • nameofthegame777 by nameofthegame777 Aug 8, 2014 4:53 PM Flag

    The conference call is a chance for the new CEO to position the company going forward, with any new leadership comes the mission statement moving forward. In order for shareholders of any publicly traded company to benefit long term from positive developments at a company you have to believe in the management team. If you asking why...it's all about the cost of financing dollars. The more confidence the higher the stock price the less dilution which doesn't negatively effect the cap base This is CEO Dr. Wotton public address to current and the very real potential of large shareholders going forward. Do I expect Dr. Wotton to leave investors with upbeat message, of course, why else did he come hear AT THS TME, surely not for the salary, that hardly jet sets you and the family to the Hampton's for more than a weekend or so. As we all know its stock and warrants he's received at very attractive prices, especially, when one considers the time consuming issues of previous managements indiscretions have been resolved

QCOM
75.62+0.96(+1.29%)Dec 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.